{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:57:11Z","timestamp":1791363431690,"version":"4.3.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaci.2026.05.023","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:42:22Z","timestamp":1781048542000},"page":"1058-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antigen-specific messenger RNA lipid nanoparticle therapy with mTOR inhibition promotes regulatory T cells and limits allergy"],"prefix":"10.1016","volume":"158","author":[{"given":"Yrina","family":"Rochman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilian R.","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Klingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kotliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett A.","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Muscat-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Barski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Lewkowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-6332","authenticated-orcid":false,"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.05.023_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.05.023_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2020.07.001","article-title":"Control of regulatory T cell homeostasis","volume":"67","author":"Buszko","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2026.05.023_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltad007","article-title":"Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective","volume":"3","author":"Sakaguchi","year":"2023","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jaci.2026.05.023_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102986","article-title":"Engineered Treg cells: the heir to the throne of immunotherapy","volume":"144","author":"Stucchi","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2026.05.023_bib10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro\u2013expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.05.023_bib11","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1073\/pnas.0701171104","article-title":"Adaptive TGF-beta\u2013dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment","volume":"104","author":"You","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.05.023_bib12","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1172\/JCI33185","article-title":"Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice","volume":"118","author":"Tsang","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.05.023_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trim.2008.02.003","article-title":"Induction of transplantation tolerance by allogeneic donor-derived CD4+CD25+Foxp3+ regulatory T cells","volume":"19","author":"Velasquez-Lopera","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell\u2013based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cei\/uxac078","article-title":"Regulatory T-cell therapy approaches","volume":"211","author":"McCallion","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2026.05.023_bib17","first-page":"111","article-title":"Messenger RNA\u2013based vaccines against infectious diseases","volume":"440","author":"Alameh","year":"2022","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"10432","key":"10.1016\/j.jaci.2026.05.023_bib19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.05.023_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics","volume":"24","author":"Wang","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"6525","key":"10.1016\/j.jaci.2026.05.023_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.05.023_bib22","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/acsnano.2c12420","article-title":"Use of a liver-targeting immune-tolerogenic mRNA lipid nanoparticle platform to treat peanut-induced anaphylaxis by single- and multiple-epitope nucleotide sequence delivery","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaci.2026.05.023_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194080","article-title":"Allergen-specific mRNA\u2013lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice","volume":"135","author":"Rochman","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.05.023_bib24","article-title":"Anionic lipids modulate mRNA\u2013lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis","author":"Melamed","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaci.2026.05.023_bib25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.05.023_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczko","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib27","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jaci.2026.05.023_bib29","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1073\/pnas.1007422107","article-title":"Enhancement of antigen-specific Treg vaccination in vivo","volume":"107","author":"Daniel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.05.023_bib30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.4049\/jimmunol.1901094","article-title":"Cutting edge: tissue antigen expression levels fine-tune T cell differentiation decisions in vivo","volume":"205","author":"Pinheiro","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1021\/acsnano.0c09206","article-title":"Antigen- and epitope-delivering nanoparticles targeting liver induce comparable immunotolerance in allergic airway disease and anaphylaxis as nanoparticle-delivering pharmaceuticals","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaci.2026.05.023_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2009.10.010","article-title":"The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and eomesodermin","volume":"32","author":"Rao","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41385-021-00480-w","article-title":"The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity","volume":"15","author":"Bain","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cell.2018.02.001","article-title":"Mapping the mouse cell atlas by microwell-Seq","volume":"172","author":"Han","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.05.023_bib36","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.05.023_bib37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41588-022-01118-8","article-title":"Systematic identification of cell-fate regulatory programs using a single-cell atlas of mouse development","volume":"54","author":"Fei","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2026.05.023_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/nar\/gkac633","article-title":"Construction of a cross-species cell landscape at single-cell level","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2026.05.023_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4049\/jimmunol.180.1.249","article-title":"Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis","volume":"180","author":"Shalev","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/eji.201847935","article-title":"Helios+ and Helios\u2212 Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires","volume":"49","author":"Thornton","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894508","article-title":"The yin and yang of targeting KLRG1+ Tregs and effector cells","volume":"13","author":"Borys","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.immuni.2018.04.023","article-title":"Amphiregulin-producing pathogenic memory T helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis","volume":"49","author":"Morimoto","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib43","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/s41467-025-57590-3","article-title":"Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma","volume":"16","author":"Khan","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.05.023_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2015.04.012","article-title":"Integrin alphavbeta8-mediated TGF-beta activation by effector regulatory T cells is essential for suppression of T-cell\u2013mediated inflammation","volume":"42","author":"Worthington","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.023_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.1501069","article-title":"Nonclassical CD4+CD49b+ regulatory T cells as a better alternative to conventional CD4+CD25+ T cells to dampen arthritis severity","volume":"196","author":"Vicente","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib48","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.1103768","article-title":"IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells","volume":"189","author":"Cheng","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaci.2022.10.006","article-title":"A homozygous truncating mutation of FGL2 is associated with immune dysregulation","volume":"151","author":"Janssen","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib50","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1073\/pnas.0706765104","article-title":"Activation of naturally occurring lung CD4+CD25+ regulatory T cells requires CD8 and MHC I interaction","volume":"104","author":"Joetham","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.05.023_bib51","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jaci.2016.06.051","article-title":"Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways","volume":"139","author":"Joetham","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib52","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib53","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaci.2026.05.023_bib54","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.3390\/ijms23147707","article-title":"Medical aspects of mTOR inhibition in kidney transplantation","volume":"23","author":"Cuadrado-Payan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.05.023_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.05.023_bib56","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.0000000716","article-title":"Mechanistic target of rapamycin inhibitors and vaccine response in kidney transplant recipients","volume":"36","author":"Perkins","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"7950","key":"10.1016\/j.jaci.2026.05.023_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-022-05628-7","article-title":"Active eosinophils regulate host defence and immune responses in colitis","volume":"615","author":"Gurtner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.05.023_bib58","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1073\/pnas.0710127105","article-title":"Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells","volume":"105","author":"Feltenmark","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.05.023_bib59","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4168\/aair.2021.13.5.684","article-title":"Arachidonic acid 15-lipoxygenase: effects of its expression, metabolites, and genetic and epigenetic variations on airway inflammation","volume":"13","author":"Xu","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2026.05.023_bib60","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.4049\/jimmunol.1302846","article-title":"Carbonic anhydrase IV is expressed on IL-5-activated murine eosinophils","volume":"192","author":"Wen","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib61","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.05.023_bib62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2019.03.001","article-title":"ZEBs: novel players in immune cell development and function","volume":"40","author":"Scott","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib63","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.4049\/jimmunol.172.4.2586","article-title":"Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation","volume":"172","author":"McMillan","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1096\/fj.03-1412fje","article-title":"Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines","volume":"18","author":"Corry","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2026.05.023_bib65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","article-title":"Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies","volume":"39","author":"Jacobsen","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib66","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.05.023_bib67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2021.11.012","article-title":"2021 year in review: spotlight on eosinophils","volume":"149","author":"Dunn","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaci.2014.08.014","article-title":"Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge","volume":"135","author":"Takeda","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.023_bib69","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1084\/jem.20172049","article-title":"Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation","volume":"215","author":"Arnold","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.05.023_bib70","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1158\/0008-5472.CAN-21-0839","article-title":"Metastasis-entrained eosinophils enhance lymphocyte-mediated antitumor immunity","volume":"81","author":"Grisaru-Tal","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2026.05.023_bib71","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41590-022-01291-2","article-title":"Eosinophil\u2013lymphocyte interactions in the tumor microenvironment and cancer immunotherapy","volume":"23","author":"Grisaru-Tal","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:58:08Z","timestamp":1791194288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926004070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0091674926004070"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-specific messenger RNA lipid nanoparticle therapy with mTOR inhibition promotes regulatory T cells and limits allergy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}